Kamath, S S <br/><br/>
The impact of radiotherapy dose and other treatment-related and clinical factors on in-field control in stage I and II non-Hodgkin's lymphoma.  [electronic resource] 

 -  International journal of radiation oncology, biology, physics  Jun 1999 
 - 563-8 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0360-3016 
<br/><br/><label>Standard No.: </label>10.1016/s0360-3016(99)00051-6  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Actuarial Analysis<br/>Aged<br/>Aged, 80 and over<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Combined Modality Therapy<br/>Cyclophosphamide--administration & dosage<br/>Doxorubicin--administration & dosage<br/>Female<br/>Humans<br/>Lymphoma, Non-Hodgkin--drug therapy<br/>Male<br/>Middle Aged<br/>Neoplasm Staging<br/>Prednisone--administration & dosage<br/>Procarbazine--administration & dosage<br/>Prognosis<br/>Radiotherapy Dosage<br/>Recurrence<br/>Survival Rate<br/>Vincristine--administration & dosage